Skip To Content

Study ID: Axovant RVT-102-2002 Nelotanserin REM sleep behavior study in DLB patient

Title:

A Phase 2, double-blind, randomized, placebo-controlled study of nelotanserin versus placebo in patients with dementia with Lewy bodies (DLB) experiencing REM sleep behavior disorder (RBD)

Location:
Fargo Region
Principal Investigator:
Tanya Harlow, MD
Disease:
Brain and Nervous System
Stage:
Phase II
Status:
Active - Open to Accrual

For more information, call or email Bismarck Clinical Research at (701) 323-5760, Fargo and Bemidji Clinical Research at (701) 234-5890, or Sioux Falls Clinical Research at (605) 328-1368.